The p53-Mdm2 module and the ubiquitin system.
By D. Michael, Moshe Oren. Seminars in Cancer Biology, 2003
814 citations recorded by the source corpus.
Subfields: Cancer Research, Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/ab5d375c24bc26f59a0d87d68c35c1e677772ef9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Molecular Biology
In Oncology
Citations in the corpus
- Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity. (2004, background): “NEDDylated p53 was ated degradation of p53, including TSG101, the retinoblas- detected in the absence of coexpressed Mdm2 (Figure toma protein (pRb), the c-Abl protooncogene product, and 2A, lane 2); however, the amount of NEDDylated p53 was p300 (Vousden, 2002; Michael and Oren, 2003).”
- Ubiquitination regulates PTEN nuclear import and tumor suppression. (2007, neutral): “Monoubiquitination has previously been implied in p53 nuclear export (Li et al., 2003; Lohrum et al., 2001), but p53 also contains several well-characterized NLS and NES sequences that enhance transport (Michael and Oren, 2003).”
- The first 30 years of p53: growing ever more complex (2009, neutral): “By contrast, in cells exposed to various stress conditions (most notably those that put the cellular genome at risk) p53 is rapidly activate”
- Acetylation is indispensable for p53 activation. (2008, background): “Recent studies have established crucial roles for both Mdm2 and Mdmx in controlling p53 activity in vivo (Michael and Oren, 2003; Marine and Jochemsen, 2005).”
- Hydrogen peroxide sensing, signaling and regulation of transcription factors (2014, background): “Like it happens for NRF2, the cellular TP53 levels are mainly regulated by its ubiquitin-mediated proteasomal degradation [190][191].”
- A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. (2004, positive): “In contrast, cells homozygous for SNP309 showed a much-weakened p53-dependent transcriptional re- binding (Michael and Oren, 2003).”